Innoscience Claims Key Legal Win in German Court, Deepening GaN Patent Feud

MUNICH, GERMANY – June 18, 2026 – The global intellectual property war over the future of power electronics intensified today as Gallium Nitride (GaN) chipmaker Innoscience declared a significant legal victory in Germany. The company announced that the Munich Regional Court issued rulings confirming its current GaN power devices do not infringe on patents held by semiconductor giant Infineon Technologies, ensuring unrestricted market access in a key European market. However, in a competing narrative, Infineon also claimed victory in the same proceedings, highlighting the complex and fiercely contested nature of this high-stakes battle for dominance in a technology critical to electric vehicles, data centers, and renewable energy.

The dueling announcements underscore a protracted global conflict that extends from German courtrooms to the U.S. International Trade Commission (ITC) and Chinese tribunals. For institutional investors and market analysts, the dispute is more than a legal squabble; it is a crucial barometer of competitive dynamics, IP strategy, and market access in one of the semiconductor industry’s fastest-growing sectors. The outcome of this multi-front war will inevitably shape the strategic landscape for next-generation power systems.

A Tale of Two Victories

At the heart of the latest development are two rulings from the Munich Regional Court. According to Innoscience, the court found that its currently marketed GaN products fall outside the scope of Infineon's asserted German patents, which are counterparts to a U.S. patent for packaging design. The company stressed that any injunction would only apply to a limited set of discontinued “legacy products”—specifically, certain 650–700V transistors—that are no longer part of its commercial portfolio. This distinction is critical, as it allows Innoscience to maintain its operational momentum and supply chains to European customers without disruption.

This narrative directly contrasts with the one presented by Infineon. The German chipmaker announced that the same court had ruled in its favor in two patent infringement cases, marking the “third and fourth legal defeat” for Innoscience in Germany. Infineon stated the court prohibited its rival from selling “additional patent-infringing products” in the country and ordered the payment of damages. This follows a previous ruling in August 2025 where the Munich court found that Innoscience had infringed a separate Infineon patent, DE102014113465B4, with other GaN products.

Reconciling these conflicting claims requires a closer look at the nuances of patent litigation. The discrepancy appears to hinge on the definition of “current” versus “legacy” products. While Infineon secured an injunction, Innoscience maintains it only affects outdated designs. This tactic of designing around existing patents while litigation unfolds is common in the fast-paced tech industry. “For a company with a rapid product development cycle, an injunction on a discontinued product is a legal setback but not a commercial catastrophe,” noted one intellectual property strategist. “It’s a calculated cost of doing business while challenging an incumbent’s market position.”

A Global IP Chess Match

The legal battle in Germany is just one front in a sprawling international conflict. The rulings in Munich closely mirror a recent determination by the U.S. International Trade Commission. Innoscience has emphasized that the ITC, like the Munich court, found its current products do not infringe Infineon’s packaging design patent. Yet, Infineon has highlighted that the ITC affirmed an earlier finding of infringement and issued import and sales bans against certain Innoscience products, underscoring the robustness of its intellectual property.

This pattern of partial victories and strategic messaging is characteristic of modern IP warfare. While Infineon leverages its vast patent portfolio—numbering around 450 GaN patent families—to defend its territory, Innoscience is proving to be a resilient challenger. The Chinese firm has not only defended its position but has also gone on the offensive, securing an injunction and a damages award against Infineon in a Chinese court. Furthermore, it has launched its own invalidity challenges against Infineon’s patents in Germany, aiming to dismantle the legal foundation of its rival’s claims.

This multi-jurisdictional approach is a deliberate strategy. By fighting in the U.S., Europe, and China, both companies are vying for control over the world’s most critical technology markets. “This isn't just a legal spat; it's a strategic battle for control over the next generation of power electronics,” an industry analyst commented. “The outcomes will dictate market access and competitive dynamics for years to come, influencing everything from supply chain diversification to R&D investment priorities.”

Beyond the Courtroom: Shaping the GaN Market

The significance of this dispute extends far beyond legal precedents. GaN technology enables smaller, lighter, and vastly more energy-efficient power conversion than traditional silicon-based chips. This makes it a cornerstone technology for decarbonization and digitalization, powering everything from compact fast chargers for consumer electronics to sophisticated power management systems in electric vehicles and hyperscale data centers.

The competitive landscape is dominated by a few key players. Infineon, an established integrated device manufacturer, solidified its leadership by acquiring GaN Systems for $830 million in 2023. This move not only expanded its product portfolio but also bolstered its already formidable IP arsenal. In contrast, Innoscience has emerged as a formidable challenger, positioning itself as the world’s largest manufacturer of GaN-on-Si power chips and aggressively expanding its global footprint.

The ongoing litigation creates a complex environment for customers who rely on these components. The threat of import bans or injunctions, however narrowly defined, introduces supply chain risk that must be managed. While Innoscience’s assurances that its core products are unaffected may soothe immediate concerns, the persistent legal uncertainty could prompt some customers to diversify their supplier base as a hedging strategy. This, in turn, could create opportunities for other GaN players to gain market share.

The legal feud also acts as a powerful signal to the investment community. Infineon’s vigorous defense of its patents is a clear message that it will protect its significant R&D investments. For Innoscience and other emerging players, the ability to successfully navigate these legal challenges is a testament to their technological independence and market resilience. The consistent validation of its current products across multiple jurisdictions, as Innoscience claims, reinforces market confidence in its innovation and compliance capabilities, proving it can compete on a global stage despite intense legal pressure from an industry titan.